Company intelligence / Profile preview

Interplexus

Kent, Washington, United States

Ownership: Private
Development stage: Other

Overview

Interplexus is a healthcare company specializing in the development and distribution of clinical-grade nutritional supplements and diagnostic testing kits. Founded in 1989, the company focuses on addressing endocrine, metabolic, and neurological imbalances through evidence-based formulations. Their product portfolio includes well-known supplements such as Seriphos, which is designed to support healthy cortisol levels and stress management. Interplexus also provides specialized diagnostic services, including salivary hormone testing, to assist healthcare practitioners in personalized patient care.

Therapeutic areas: Metabolic DisordersPsychiatryEndocrinology
Modalities: Small moleculeBotanical extract
Industry: Food & Nutrition

Beyond the preview

Go deeper on Interplexus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interplexus.

Explore the full profile